Clinical Efficacy of Heparin Fractions: Issues and Answers

1 January 1986

journal article
research article
Published by Taylor & Francis in CRC Critical Reviews in Clinical Laboratory Sciences

Vol. 23 (2), 77-94
https://doi.org/10.3109/10408368609165796

Abstract

(1986). Clinical Efficacy of Heparin Fractions: Issues and Answers. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 23, No. 2, pp. 77-94. doi: 10.3109/10408368609165796

Keywords

This publication has 75 references indexed in Scilit:

Anwendung von niedermolekularem Heparin bei Hämodialysepatienten
Klinische Wochenschrift, 1985
Effect of heparin on platelet aggregation
American Journal of Hematology, 1984
Natural anticoagulant mechanisms.
Journal of Clinical Investigation, 1984
Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis
Klinische Wochenschrift, 1984
TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOSIS BY NEW HEPARINOID
The Lancet, 1983
ASPIRIN PREVENTS HEPARIN‐INDUCED PLATELET AGGREGATION IN VIVO
British Journal of Haematology, 1983
The LeVeen Shunt for Ascites and Hepatorenal Syndrome
New England Journal of Medicine, 1980
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Journal of Clinical Investigation, 1980
WARFARIN-INDUCED FETAL ABNORMALITIES
The Lancet, 1976
The Platelet Aggregating Effect of Eight Commercial Heparins
Scandinavian Journal of Haematology, 1972

Cited by 8 articles